Resultados de la búsqueda 321-330 de 3920 para anti-TNF drugs
abril 2024. DEA Drug Take Back Day at Mayo Clinic in Florida April 23, 2024, 02:30 p.m. CDT · Mayo Clinic Minute: Creating an advance directive for your future ...
The purpose of this study is to assess how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment ...
This phase III trial compares memantine to usual treatment in treating patients with brain tumors that are newly diagnosed or has come back (recurrent).
... treatment participants get is decided by chance. Semaglutide is a medicine, doctors can prescribe in some countries for the treatment of type 2 diabetes.
... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...
July 12, 2024, 03:12 p.m. CDT · Drugs that kill "zombie" cells may benefit ... Hormone therapy: Four things a Mayo Clinic women's health specialist wants ...
Anti-cancer activity will be assessed every 6 weeks during therapy and every 12 weeks thereafter. Establishment of Preclinical Models from Patients with ...
... treatment or non-treatment (placebo) arm. Participants in the treatment arm will take the supplement drug for 2 days. For all participants, an olive-sized ...
... Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition of ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?